TRH, an amidated tripeptide secreted by certain hypothalamic neurons, is a principal regulator of TSH secretion and thyroid hormone release. TRH is also produced by other neurons in the central nervous system, where it appears to function as a neuromodulator or neurotransmitter, and by certain endocrine cells, where it may act as an autocrine or paracrine factor. The genomic organization of the rat TRH (rTRH) gene is well understood; however, the domains of the rTRH gene that regulate expression are less well characterized. We observed that the region between Ϫ47 and ϩ6 of the rTRH gene (relative to the transcription start site at ϩ1) was active in CA-77 cells, a medullary thyroid carcinoma cell line model of TRH production, but was not active in transgenic mice. Inclusion of most of exon 1 (84 out of 103 bp; Ϫ47 to ϩ84) increased promoter activity in CA-77 cells and was active in transgenic mice, principally in tissues that normally express the TRH gene. Further lengthening of the 5Ј end to Ϫ243, Ϫ547, or Ϫ776 retained this expression in TRH-producing tissues in transgenic mice, while further increasing activity in CA-77 cells. These results suggest that cis element(s) located within exon 1 are necessary for the expression of the rTRH gene in vivo. (Endocrinology 139: [252][253][254][255][256][257][258][259] 1998) T HE hypothalamic peptide hormone TRH (pGlu-HisproNH 2 ) is processed from a larger proTRH molecule (1, 2). TRH produced in the paraventricular nucleus of the hypothalamus regulates TSH secretion from the anterior pituitary (3) and is, therefore, an integral component for maintaining thyroid hormone homeostasis. TRH-containing neurons are also found in other regions of the hypothalamus (4) and in many areas of the central nervous system (CNS) including, but not limited to, cells of the olfactory bulb, the reticular nucleus of the thalamus, and the motor nucleus of the vagus (5). In other CNS regions, TRH appears to function both as a neurotransmitter and as a neuromodulator (3, 4). Processing of proTRH in certain regions of the CNS also results in the formation of TRH-related peptides (6).
T HE hypothalamic peptide hormone TRH (pGlu-HisproNH 2 ) is processed from a larger proTRH molecule (1, 2) . TRH produced in the paraventricular nucleus of the hypothalamus regulates TSH secretion from the anterior pituitary (3) and is, therefore, an integral component for maintaining thyroid hormone homeostasis. TRH-containing neurons are also found in other regions of the hypothalamus (4) and in many areas of the central nervous system (CNS) including, but not limited to, cells of the olfactory bulb, the reticular nucleus of the thalamus, and the motor nucleus of the vagus (5) . In other CNS regions, TRH appears to function both as a neurotransmitter and as a neuromodulator (3, 4) . Processing of proTRH in certain regions of the CNS also results in the formation of TRH-related peptides (6) .
Authentic TRH is also found in cells of certain endocrine tissues, including pituitary (7), testis (8) , thyroidal C (9, 10), heart (11), prostate (12) , ovary (12) , placenta (13) , and pancreas (12) . Similar to somatostatin (14) and corticotropinreleasing hormone (15) , two peptides initially discovered in the hypothalamus but later found in other locations, TRH produced in endocrine tissues is thought to function in an autocrine or a paracrine manner.
The human (2) and rat (1) TRH genes each consist of three exons. Exon 1 is not translated. Exons 2 and 3 encode the entire preproTRH sequence, with all copies of the TRH sequence located within exon 3. The molecular mechanisms controlling the specific sites and extent of TRH gene expression are poorly understood. However, studies of other peptide hormones, notably GH and PRL in anterior pituitary cells (16) , and calcitonin (17) and somatostatin (18, 19) in thyroidal C cells, have identified a growing number of tissuespecific transcription factors in eukaryotic cells. Most of these transcription factors bind to DNA elements that can enhance or silence transcription in a manner relatively independent of orientation and location within the gene. This scenario contrasts with the initiation of transcription involving TATA and other sequences located near the RNA transcription start site, whose function depends on relatively strict orientation and placement within the proximal 5Ј region of a gene (20) . The 5Ј region of the rat TRH gene contains TATA and GC box sequences (1, 21) found in the promoter region of numerous other genes, as well as consensus sequences for cAMP response element (CRE) and thyroid hormone response element (22) . Similar to somatostatin (23) and calcitonin (24) , these cis elements may help to regulate the levels of TRH gene expression (22) . Reported experiments designed to define the regulatory elements in the TRH gene have been limited to cell culture studies, primarily using CA-77 cells, a TRH-secreting medullary thyroid carcinoma cell line (21, 22, 25) . Previous studies have shown that the region between Ϫ113 and Ϫ47 is necessary for increased expression of the rat TRH (rTRH) gene in CA-77 cells (22) . Located in this region are two cis elements that are homologous to the consensus CRE/thyroid hormone response elements and thought to be at least partially responsible for this increased activity in CA-77 cells (22) . However, our data indicate that although these upstream elements may modulate the levels of TRH gene expression in vitro, they are not responsible for directing expression of the rTRH gene to TRH-producing tissues in vivo.
Our results indicate that sequences located between ϩ6 and ϩ84 of the first exon of the rTRH gene are crucial for generating reporter gene activity in transgenic mice but have a less-important role in CA-77 cells. A truncated rTRH promoter region containing only the DNA between Ϫ47 and ϩ6 (53 bp) ligated to the reporter gene luciferase was inactive in transgenic mice in contrast to its low (but significant) level of activity in CA-77 cells. A longer region of the rTRH gene, containing the 84 bp (of 103 bp) of exon 1 (Ϫ47/ϩ84) was active in transgenic mice, primarily in TRH-containing tissues. This region was also active in CA-77 cells; however, both the Ϫ47/ϩ6 and the Ϫ47/ϩ84 promoter regions were much less active in CA-77 cells than three progressively longer segments (Ϫ776/ϩ84; Ϫ547/ϩ84; Ϫ243/ϩ84). These results indicate that sequences within the first exon appear to be necessary for TRH gene expression in TRH-containing tissues in vivo, and that the expression of TRH in transgenic mice and in CA-77 cells appears to be regulated by a complex interaction of cis elements.
Materials and Methods

Cloning of rat TRH 5Ј flanking and 5Ј untranslated regions
Clones containing the rat TRH 5Ј flanking and untranslated regions (exon 1) were isolated from a rat genomic library composed of a Sau3AI partial digest of Sprague-Dawley rat liver DNA cloned into EMBL3 (Clontech, Palo Alto, CA). The 32 P-labeled HindIII-PstI fragment of the plasmid pSL2 (1) (a gift of Dr. S. L. Lee, Tufts University and New England Medical Center) was used to screen the genomic library (26) . Four clones were isolated, each containing the hybridizing region within an approximately 6-kb EcoRI-BamHI fragment, and cloned into the plasmid pGEM7zf(ϩ) (Promega, Madison, WI). By restriction digests and partial sequencing by the dideoxy-chain termination method (Sequenase Kit, United States Biochemical, Cleveland, OH) (27) , all four clones appeared identical. Both DNA strands of one clone were sequenced further, and all data reported was based on this clone.
DNA constructs
The DNA constructs for both transfection and transgenes were made in the pNASS␤ vector (Clontech), in which the bacterial LacZ coding region was replaced by the complementary DNA (cDNA) for firefly luciferase (28) to generate the vector, pNASS-Luc. Each of the rTRH 5Ј flanking regions was filled in with Klenow (Boehringer Mannheim, Indianapolis, IN) and blunt-end ligated into the filled-in XhoI site in the polylinker upstream of the SV40 intron. This ligation results in the loss of the PstI site. For transgenic mice, these constructs were linearized by digestion with NdeI and PstI, which cut 269 bp upstream of the 5Ј flanking region and immediately downstream of the SV40 polyadenylation site, respectively.
For cell culture and transgenic mouse studies, five progressively shorter promoter regions were cut out of the 6-kb rTRH clone and ligated into the pNASS-Luc vector. The promoter region was cut with PvuII, HindIII, AatII and NarI, at Ϫ776, Ϫ547, Ϫ243, and Ϫ47 (relative to the transcription start site at ϩ1), respectively, and with either PstI, which cuts at ϩ84, or SalI, which cuts at ϩ6.
Cell culture and transfection
CA-77 (medullary thyroid carcinoma) cells were grown as described (9, 29, 30) . Briefly, cells were passaged in medium composed of 1:1 (vol/vol) DMEM/F10 (Gibco-BRL, Gaithersburg, MD) plus 10% FBS (Hyclone, Provo, UT). Within 24 h this medium was changed to DMEM/ F10 plus 10 g/ml insulin, 5 g/ml transferrin, 3 ϫ 10 Ϫ8 m selenium (ITS) (all from Sigma Chemical Co., St. Louis, MO). For transfection, cells were passaged into 6-well plates at 600,000 cells/well in medium DMEM/F10/ITS. Cells were transfected using 10 l lipofectamine (Gibco-BRL) plus 1 g rTRH-luciferase and 0.2 g cytomegalovirus (CMV)-␤-galactosidase plasmid (Invitrogen, San Diego, CA), per manufacturer's directions.
Forty-eight hours after transfection, cells were washed with PBS and lysed in lysis buffer (31) . Cell extracts were assayed for luciferase activity as described by Braiser et al. (31) . Briefly, cells were lysed in a glycylglycine-and Triton X-100 -containing buffer and centrifuged to remove cellular debris. An aliquot of the supernatant was assayed for luciferase activity after the addition of a buffer containing 0.2 mm luciferin and 2 mm ATP (Sigma). Luciferase activities were quantified using a BioOrbit Model 1251 luminometer (Pharmacia, Gaithersburg, MD). ␤-galactosidase activity was determined as described (27) . Data were calculated as arbitrary light units/␤-galactosidase activity and reported as fold increase over cells transfected with both the pNASS-Luc and CMV-␤-galactosidase plasmids. All transfections were done in triplicate.
LNCaP cells, a prostate cancer cell line, were grown in DMEM (Gibco-BRL) supplemented with 10% FBS (Hyclone). For transfection, cells were split 1:10 into 6-well plates. Cells were transfected using lipofectamine with the rTRH-luciferase and CMV-␤-galactosidase plasmids as above but in DMEM alone. This medium was replaced with DMEM plus 10% FBS after 5 h. As positive control, cells were transfected with a plasmid containing a mouse mammary tumor virus enhancer upstream of the luciferase cDNA and exposed to 5 ϫ 10 Ϫ8 m of the synthetic androgen mobolerone (R1881) (Amersham, Arlington Heights, IL) or vehicle (ethanol).
Transgenic mice
All animal studies were conducted in accordance with the principles and procedures outlined in Guidelines for Care and Use of Experimental Animals. Transgenic mice were generated by standard techniques (32) . Fertilized eggs were obtained from either FVB/N ϫ FVB/N or C57/ Bl/6JxSJL F 1 ϫ C57Bl/6JxSJL F 1 matings (both strains from Jackson Labs., Bar Harbor, ME). The strain of mouse did not appear to affect expression of the transgene. Genomic DNA obtained from tail biopsies was isolated as described by Hogan et al. (32) . DNA (20 g) from founder mice was analyzed by Southern blot onto Nytran membranes (Schleicher and Scheull, Keene, NH) (26) and for some of the mice also by PCR (see below). Mice derived from these founders were analyzed by slot blot using the Minifold II apparatus (Schleicher and Scheull) and Nytran membrane and/or by PCR. Blots were probed with a 32 P-deoxycytidine triphosphate-labeled EcoRI to XbaI fragment (590 bp) and/or an EcoRI (1251 bp) fragment of the luciferase cDNA. Hybridizations were carried out in a Techne HB-1 hybridization oven (Techne, Princeton, NJ) at 42 C in 50% formamide, 6ϫ SSC, 0.05 m NaPO 4 , 5ϫ Denhardt's, 0.1% SDS, and 100 g/ml calf thymus DNA. Blots were washed sequentially with 1ϫ SSC/0.1% SDS at room temperature and 0.1ϫ SSC/0.1% SDS at 60 C (26) . For PCR analysis, the oligodeoxynucleotides used were: 5Ј-AAGCCTCAGCCCCTCCTCG-3Ј and 5Ј-TATGTTTTTGGCGTCTTG-GAT-3Ј, which were homologous to the sequence between bp Ϫ25 and Ϫ5 of the rTRH gene and bp 304 and 324 of the firefly luciferase cDNA (28), respectively. PCR was carried out by an adaptation of the procedure described by Drews et al. (33) .
At least six transgenic mouse lines were generated with each of the rTRH promoter constructs (transgenes). All animals were fed (Purina Lab Chow, Purina, St. Louis, MO) and watered ad libitum and kept on a 12 h light/12 h dark schedule.
Dissections
Mice between the ages of 8 and 52 weeks were dissected. Mice were killed by CO 2 inhalation. Tissues were removed, blotted on paper towels, immediately frozen on dry ice, and stored at Ϫ80 C until analyzed. The tissues taken were: hypothalamus, olfactory bulb, hindbrain (primarily cerebellum and medulla obtained by making a razor blade cut posterior to the hypothalamic sulcus after removal of the hypothalamus), pituitary, liver, pancreas, kidney, spleen, skeletal muscle (quad-riceps femoris), testis, ventral prostate, ovary, atrium, ventricle, and lung. Mouse tissues were sonicated in the lysis buffer (31) and analyzed as described above. Protein levels were determined as described by Bradford (34) 
Results
Constructs
The DNA constructs and transgenes that were used are shown in Fig. 1 . Progressively shorter regions of the 5Ј flanking region (truncated promoter regions) of the rTRH gene were ligated to the firefly luciferase cDNA (28) (Fig.  1) . The four longest constructs were composed of either 776, 547, 243, or 47 bp of the 5Ј flanking region plus the first 84 of 103 bp of (the untranslated) exon 1, respectively. The shortest segment contained 47 bp of the 5Ј flanking region plus only 6 bp of exon 1. The progressively shorter reporter constructs/transgenes were designated: Ϫ776/ϩ84rTRH, Ϫ547/ϩ84rTRH, Ϫ243/ϩ84rTRH, Ϫ47/ϩ84rTRH, and Ϫ47/ϩ6rTRH, respectively.
Further sequencing of 5Ј portion of rTRH gene
The sequence of less than 500 bp of the 5Ј flanking region of the rTRH gene has been reported previously (1, 21) . We sequenced an additional 402 bp upstream (total of 900 bp: Ϫ784/ϩ103 (all of exon 1) plus 13 bp of intron 1 of the rTRH gene (Fig. 2) to extend these reports. This additional sequence could also help to identify cis elements further upstream that might influence the expression of the rTRH gene and help to establish the basis for future deletion and mutagenesis studies. Our sequence up to Ϫ406 (519 bp) was virtually identical to previous reports (1, 21) , with a few minor differences: 1) four cases of a single base pair present in the previous sequence (at Ϫ396, Ϫ369, Ϫ343, Ϫ188) but not in our sequence (see Fig. 2 ); 2) three examples of a single base pair addition in our sequence (Ϫ381, Ϫ316, Ϫ242), one of which (Ϫ316) was reported previously (21) ; and 3) a 1-bp substitution (C3 A) at Ϫ373. Upstream of Ϫ406 our sequence agrees with Lee et al. (21) , except for an A not present in our sequence (after Ϫ497 in our sequence) and an 8-bp region located between Ϫ432 and Ϫ425 present in our sequence (Fig. 2) . These minor differences probably resulted from sequencing different clones or alleles.
In addition to the cis elements previously identified (1, 21, 22), we found sequences that resemble other known enhancer elements (Fig. 2) : 1) the sequence GGGCGGG, located at Ϫ693 is a GC box and contains the hexanucleotide (GGGCGG) that interacts with the SP1 transcription factor (35); 2) the sequence CCAGG at Ϫ770 that is identical to a neuronal-specific enhancer (36); and 3) the sequence CCTTTATTTTG (beginning at Ϫ351) that bears a striking similarity to the 10-bp atrial natriuretic peptide (ANP) CArG element, CCTTATTTGG (37), a sequence that confers cardiac-specific expression. In addition, there are two long repeats-one of 26 bp and one of 27 bp-beginning at Ϫ755 and Ϫ582, respectively. At Ϫ755, the 26-bp sequence TTTCCACAGAAGCCAGTTTTGTTCTT (Fig. 2, distal 26 -bp repeat; underlined nucleotides are identical in both sequences) contains 20 nucleotides that are identical to the second sequence (beginning at Ϫ582), TTCTCACAGGTCCCCATTTTTGTTCTT (Fig. 2 , proximal 27-bp repeat). These homologous sequences comprise two components, the virtually identical 3Ј-most 13 nucleotides CA G / T TTTTGTTCTT, and the more degenerate 5Ј 13 or 14 nucleotides containing a common TTYYCACAG (where Y ϭ C or T). Within the 3Ј component is a consensus glucocorticoid response element half-site (TGTTCT) (38) . It is unknown whether these cis elements participate in the glucocorticoid stimulation of the TRH gene observed in hypothalamic cell cultures (39), CA-77 cells (40) , and anterior pituitary cells (41, 42) 
in vitro.
Cell culture studies CA-77 cells, a rat medullary thyroid carcinoma cell line, secrete TRH (9, 30) and represent a model for studying regulation of TRH gene expression (21, 22, 40) . Using these cells, we confirmed previous results (21, 22 ) that cells transfected with the Ϫ776/ϩ84rTRH, Ϫ547/ϩ84rTRH, and Ϫ243/ϩ84rTRH constructs generated significantly more luciferase activity than cells transfected with the Ϫ47/ϩ84rTRH or the vector alone (Fig. 3) . However, there are no reports concerning the activity of the Ϫ47/ϩ6rTRH region. Cells transfected with the Ϫ47/ϩ84rTRH and Ϫ47/ϩ6rTRH constructs exhibited 4-to 6-fold and 2-to 3-fold increased levels of luciferase over baseline, respectively. These increases were significant compared with the vector alone, although less than the 12-to 18-fold increase observed with the three longer rTRH promoter constructs. Similar results were obtained when cells were grown as described by Russo et al. (29) , so that they attained either a more neuronal or endocrine phenotype (data not shown). The data with CA-77 cells suggests that elements upstream of Ϫ47 are generally stimulatory, although the presence of individual repressive elements cannot be ruled out by this study. To test whether or not the increased (over baseline) activity of the shortest (Ϫ47/ϩ6rTRH) region could be attributed to nonspecific expression due to DNA elements such as a TATA box, the prostate cancer cell line LNCaP, a cell line that does not appear to produce TRH (our unpublished observation), was transfected with all five rTRH-luciferase constructs. No luciferase activity was observed with any of the constructs.
FIG. 1. Schematic diagram of rTRH 5Ј
flanking-5Ј untranslated regions-luciferase transgenes. Five transgenes generated were Ϫ776/ ϩ84rTRH, Ϫ547/ϩ84rTRH, Ϫ243/ϩ84rTRH, Ϫ47/ϩ84rTRH, and Ϫ47/ϩ6rTRH. 3Ј end of four longest transgenes was ϩ84. Positions of restriction sites and restriction enzymes used to generate truncated 5Ј flanking regions are shown relative to transcription start site at ϩ1 (arrowhead).
Expression of rTRH-luciferase transgenes in transgenic mice
Ϫ47/ϩ84rTRH and Ϫ47/ϩ6rTRH transgenic mice. The activity of the Ϫ47/ϩ84rTRH and Ϫ47/ϩ6rTRH in CA-77 cells prompted us to examine whether these promoter regions could also direct expression to TRH(ϩ) (TRH-containing) tissues in transgenic mice. Transgenic mouse lines were generated by conventional means (32) with 18/57 and 8/35 pups transgenic for the Ϫ47/ϩ84rTRH and Ϫ47/ϩ6rTRH, respectively. We determined the luciferase activity in many TRH(ϩ) tissues: hypothalamus, olfactory bulb, hindbrain, pituitary, pancreas, atrium, ventricle, ovary, and testis and TRH(Ϫ) (non-TRH-expressing) tissues: skeletal muscle, liver, kidney, spleen, and lung. The amount of luciferase activity observed in these transgenic mice was unrelated to either the transgene copy number or the age of the animals (8 -52 weeks old).
Two of the 18 transgenic mice containing the Ϫ47/ ϩ84rTRH transgene neither exhibited luciferase in any tissues nor passed the transgene onto their offspring, suggesting that these mice were mosaic for the transgene. Comparisons of the luciferase activities found in TRH(ϩ) hypothalamus and olfactory bulb and TRH(Ϫ) liver of the remaining 16 lines of transgenic mice are illustrated in Fig.  4D . Two (lines 2383 and 2386) of the 16 lines of mice contained little or no luciferase activity in any tissue except for testis. The remaining 14 lines of mice had luciferase in most TRH(ϩ) tissues. Two of these lines (2406 and 2583) had very low levels (Ͻ1 light unit/mg protein) in hypothalamus (Fig.  4D) , although in other TRH(ϩ) tissues the levels were higher. The remaining 12 lines of mice had hypothalamic levels ranging from 1557 to 2.5 light units/mg protein (Fig. 4D) . In 11/16 lines, luciferase activity in the olfactory bulb was generally greater than in the hypothalamus (Figs. 4D and 5D ). Prostatic and pancreatic levels were extremely low or undetectable, and in about half of the lines, no luciferase activity was observed in either the atrium or ventricle. In general, TRH(Ϫ) tissues exhibited low or undetectable expression. Of the TRH(Ϫ) tissues, skeletal muscle consistently contained the highest levels of luciferase and was positive in 10/16 lines. The luciferase activities from all of the tissues studied from line 613 are shown in Fig. 5D .
In contrast to the Ϫ47/ϩ84rTRH transgenic mice and the results in CA-77 cells transfected with the Ϫ47/ϩ6rTRH construct (Fig. 3) , 7/8 lines of transgenic mice containing the Ϫ47/ϩ6rTRH transgene failed to produce luciferase activity in any of the tissues examined, except for low levels
Sequence of rat TRH promoter region from Ϫ784 to intron 1. Double-stranded sequencing of insert was performed by dideoxy-mediated chain-termination method (27) . Nucleotide at ϩ1 represents start site for RNA transcription (1) . Numbers above sequence are relative to transcription start site (ϩ1). Proximal and distal repeats (underlined) represent 27-bp and 26-bp repeated sequences, respectively (see text). Sequence CCAGG at Ϫ770 (neur.enh) is identical to a consensus neuronal enhancer element (35) . GC box/SP1 consensus sequences are indicated at Ϫ119 and Ϫ643 (double underlined) (36) . ANP-CArG-like represents sequence (underlined) with homology to CArG element from ANP gene (37) . Sites for restriction enzymes used for making rTRH promoter constructs are indicated. Asterisks (*, **) represent limit of two sequences reported by Lee et al. (1, 21) . GenBank accession number: AF024518 in some testes (three lines: 2389, 2368, 3318) and ovaries (one line: 2389) (Figs. 4E and 5E ). When measurable, luciferase activity in testis was very low (Fig. 5E) , unlike the higher levels seen in this tissue with the four longer transgenes (Fig.  5, A-D) . Figure 5E illustrates the levels of luciferase activity of representative line 2389. Only the eighth line of these transgenic mice (line 3319) exhibited luciferase activity in nonreproductive tissues (Fig. 4D) . This activity was seen in all tissues, suggesting that expression of this transgene was due to a position effect, i.e. its activity was influenced by its site of integration into the mouse's genome (43) and was not solely under the control of the transgene.
These data indicate that transgenes containing 84 bp of exon 1 and 47 bp or more of the 5Ј flanking sequence possessed sufficient information for expression of the rat TRH gene primarily in TRH(ϩ) tissues in transgenic mice. Removal of 78 bp of exon 1, leaving the 53-bp region between Ϫ47 and ϩ6, greatly diminishes but does not eliminate activity in CA-77 cells, but virtually eliminates this activity in transgenic mice. This inability to promote expression of a reporter gene in transgenic mice indicates that cis elements located in exon 1, between ϩ6 and ϩ84, play a crucial role for expression of the rTRH gene in transgenic mice.
Ϫ776/ϩ84rTRH, Ϫ547/ϩ84rTRH, and Ϫ243/ϩ84rTRH transgenic mice. Because the activity of the Ϫ47/ϩ84rTRH transgene was often low or undetectable in some TRH(ϩ) tissues, we wanted to determine whether increasing the amount of the 5Ј flanking sequence influences the activity of the transgene, similar to the increase observed in CA-77 cells (21, 22) (Fig. 3) . With the Ϫ776/ϩ84rTRH, Ϫ547/ϩ84rTRH, and Ϫ243/ϩ84rTRH transgene, 7/25, 6/31, 9/49 pups were transgenic, respectively. For the longest transgene (Ϫ776/ ϩ84rTRH), all TRH(ϩ) tissues exhibited luciferase activity, except that ovary, pancreas, and prostate, which have low levels of endogenous TRH (12), contained little or no measurable luciferase. Olfactory bulb levels were consistently higher than hypothalamus (Figs. 4A and 5A ). Testis always displayed the highest levels of luciferase activity, which were 40-to more than 1000-fold greater than in hypothalamus (Fig.  5A and data not shown), despite endogenous TRH levels in the testis being much lower than in the hypothalamus (8) . Luciferase activity in TRH(Ϫ) tissues was either below the level of detection or was low relative to TRH(ϩ) tissues (Fig.  5A and data not shown) . The highest levels of luciferase in a TRH(Ϫ) tissue were seen in skeletal muscle in most transgenic mouse lines (Fig. 5A and data not shown) ; however, these levels were always lower than in TRH(ϩ) tissues.
The next longest transgene, Ϫ547/ϩ84rTRH, also exhibited luciferase activity in all TRH(ϩ) tissues, and the levels in ovary, pancreas, and prostate were easily detectable, al- though still low, in virtually all lines (Figs. 4B and 5B). Generally, olfactory bulb levels approximated those found in hypothalamus. Testicular luciferase was high in four lines, but quite low in the other two. More of the TRH(Ϫ) tissues consistently displayed luciferase activity, with skeletal muscle once again containing the highest amount of luciferase.
Transgenic mice with the Ϫ243/ϩ84rTRH transgene were more similar to the Ϫ776/ϩ84rTRH than the Ϫ547/ ϩ84rTRH line with respect to the tissue distribution of luciferase. Olfactory bulb levels were either higher or equivalent to hypothalamus. Testis in all lines contained very high levels of luciferase. Again, expression in TRH(Ϫ) tissues was very low or below detection (Figs. 4C and 5C ). The influence of individual cis elements, whether repressive or stimulatory, is difficult to ascertain in these transgenic mice, because the levels of luciferase activity varied between lines. However, the variations among these transgenes suggest that an interaction of cis elements in the 5Ј flanking region (Fig. 2) modulates the levels of expression of the rTRH gene.
Discussion
Expression of the TRH gene is limited to specific regions in the CNS, notably in the hypothalamus and olfactory bulb (3, 5) , and outside of the CNS to certain organs (3, 8 -11) . To understand better the regulation of TRH gene expression, we examined the activity of progressively shorter regions of the rTRH promoter region in CA-77 cells, a TRH-producing, medullary thyroid carcinoma cell line, and in vivo in transgenic mice. Our results confirmed that in CA-77 cells the activity of the region between Ϫ47 and ϩ84 was greater than baseline (vector alone), and that this activity was significantly lower than in cells transfected with longer promoter segments (Ϫ776/ϩ84rTRH, Ϫ547/ϩ84rTRH, and Ϫ243/ ϩ84rTRH) (21, 22; Fig. 3 ). We showed that removal of 78 bp of the first exon significantly reduced, but did not eliminate, expression in CA-77 cells (Fig. 3) . These results suggest that proximal and distal cis elements interact to regulate the activity of the rTRH gene in CA-77 cells.
That a short region of the promoter is active in CA-77 cells has a precedent: the expression of somatostatin, another neuropeptide initially found in the hypothalamus and later seen elsewhere. CA-77 cells secrete somatostatin in addition to TRH (23) . Expression of the somatostatin gene in CA-77 cells also requires only a short region of the promoter, between Ϫ50 and ϩ50. Removal of a CRE located between Ϫ50 and Ϫ40 of the somatostatin gene eliminates this expression (44) . In contrast, removal of a region of the rTRH gene containing CREs reduces but does not eliminate activity in CA-77 cells (21, 22) (Figs. 2 and 3) , indicating that some expression from the rTRH gene is independent of these CREs. Because removing most of the exon 1 (Ϫ47/ϩ6rTRH) decreases but does not eliminate expression in CA-77 cells (Fig. 3) , cis elements must be located between Ϫ47 and ϩ6. Other than the TATA box, no elements that have been implicated in mediating the regulation of the rat (1, 21, 22) (Fig. 2) or human (25) TRH genes were observed (Fig. 2) . When the five regions of the rTRH gene were examined in transgenic mice, we observed that the four longest ones generated luciferase activity primarily in TRH(ϩ) tissues (Figs.  4, A-D and 5, A-D) . The low levels of luciferase found in tissues such as ovary, pancreas, and prostate were consistent with the endogenous levels of authentic TRH found normally in these tissues (12) . In contrast to the results obtained with the four longest regions and with results in CA-77 cells, the Ϫ47/ϩ6rTRH transgene was virtually inactive in transgenic mice (Figs. 4E and 5E ). The exonic region between ϩ6 and ϩ84 must therefore contain DNA sequences that are necessary for activity in transgenic mice.
Although there are increasing examples of intragenic regulatory elements, in most cases these elements are located within introns rather than exons. Only two examples of exonic elements that regulate tissue-specific activity in transgenic mice have been reported. These elements were found in the human keratin (45) and the murine Hoxd-11 genes (46). In both of these studies, downstream exons were implicated as containing the cis elements. These two studies, in addition to our report, illustrate that regulatory sequences within exons are active in vivo.
We observed that including contiguous segments of the rTRH gene upstream of Ϫ47 produced luciferase activity in TRH(ϩ) tissues more consistently. This activity appears to mimic more accurately the tissue distribution of TRH and may be related to the variety of cis elements located within the proximal 784 bp of the rTRH flanking sequence, many of which have been discussed previously (1, 21) . A neuronal enhancer element CCAGG (36) , located at Ϫ770 (Fig. 2) , may be involved in the expression of TRH in the CNS. An 11-bp sequence CCTTTATTTTG, beginning at Ϫ351 of the rTRH 5Ј flanking region, is homologous to the 10-bp ANP CArG element (37) . This element may participate in the expression of TRH in the heart, where atrial and ventricular TRH expression is differentially regulated both at the transcriptional and translational level (8) . The seven E-box consensus sequences (47) (at Ϫ779, Ϫ707, Ϫ623, Ϫ373, Ϫ297, Ϫ290, Ϫ214; Fig. 2 ) may be involved in the expression of luciferase in skeletal muscle, a TRH(Ϫ) tissue, although skeletal muscle expression was seen with the Ϫ47/ϩ84rTRH transgene, which contains no E-box elements. The E-box consensus sequence, CANNTG, is found in the regulatory regions of most muscle-specific genes and appears to be required for the correct expression of muscle-specific genes during development (47) . E-box-like elements also enhance the expression of calcitonin in thyroidal C cells (48) . The function of the proximal and distal repeats (Fig. 2) is also unclear. Each repeat contains a half-site glucocorticoid response element but no other obvious homologies to known cis elements. The precise role of all of these elements in regulating expression of the rTRH gene in vivo is unknown, because even in their absence, luciferase activity was observed in TRH(ϩ) tissue (Figs. 4,  A-D and 5, A-D) . They may, however, exert an important influence within the context of the endogenous gene. Although it appears clear that the region between ϩ6 and ϩ84 of the rTRH gene is important for regulating the activity of the rTRH gene in transgenic mice, the presence of these other regulatory elements suggests that the control of rTRH gene expression is complex. The interaction of upstream and downstream elements in the rTRH gene is likely to be the mechanism for regulating TRH gene expression in vivo.
